IBT Factsheet September 2014

Disclaimer

You are seeing this because you are accessing IBT’s website for the first time.

The information on this website may only be suitable for certain types of investors and is not intended to be used or relied upon by any other person.

An investment with IBT may contain significant risks and is intended only for sophisticated investors who meet certain eligibility criteria.

The material on this website is intended to be viewed only by persons resident in the EEA.

The information on this website is not an offer to sell or a solicitation of an offer and does not constitute investment advice.

No representation, warranty or undertaking, express or implied, is given as to the accuracy or completeness of the information or opinions contained therein.

The information on this website may constitute financial promotion for the purposes of the Financial Services and Markets Act 2000 (“FSMA”).

OUR AWARDS

News / Media

5th December 2018Why an Investment Trust Works Well for a Biotechnology Allocation

While the benefits of investment trusts are well-understood, it’s less obvious why these vehicles are a particularly good fit for an allocation to the biotechnology sector.
Read More
14th November 2017WINNER - Citywire Best Specialist Equities 2017

International Biotechnology Trust (IBT) triumphed in an eclectic category at the Citywire Investment Trust Awards, seeing off competition from property, technology and environmental funds to be crowned best Specialist Equities trust.
Read More

Contact Us

International Biotechnology Trust plc ("IBT") is an investment trust company listed on the London Stock Exchange which invests in the biotechnology sector. The portfolio aims to capture the best chances of clinical, regulatory and commercial success from a diversified portfolio of public and private biotechnology investments.